Grantham and District Hospital, is an NHS hospital in Grantham, Lincolnshire, England. It is managed by United Lincolnshire Hospitals NHS Trust.

There are 184 beds in Grantham and District Hospital.

During the past decade, Grantham and District Hospital conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Grantham and District Hospital" #1 sponsor was "University College, London" with 3 trials, followed by "University of Leeds" with 2 trials sponsored, "3M" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Institute of Cancer Research, United Kingdom" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Grantham and District Hospital" #1 collaborator was "Cancer Research UK" with 4 trials as a collaborator, "Takeda" with 2 trials as a collaborator, "Celgene" with 1 trials as a collaborator and "Medical Research Council" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Grantham and District Hospital" are "Multiple Myeloma" (2 trials), "Prostate Cancer" (2 trials), "Anemia" (1 trials), "Atrial Fibrillation" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Grantham and District Hospital" in a lesser frequency.

Most popular intervention types in "Grantham and District Hospital" are "Drug" (8 trials), "Other" (2 trials), "Procedure" (2 trials), "Biological" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "laboratory biomarker analysis" (2 trials), "Anastrozole" (1 trials), "Aspirin" (1 trials), "Augmented autologous stem cell transplant (ASCT-aug)" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Grantham and District Hospital" are 7 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Grantham and District Hospital". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Grantham and District Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Grantham and District Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".